Precision Medicine: Its Promises and Pitfalls Melissa S. Creary, PhD, MPH Health Management and Policy U-M School of Public Health

Similar documents
Human Genomics, Precision Medicine, and Advancing Human Health. The Human Genome. The Origin of Genomics : 1987

Setting the stage: Privacy, security, regulation, and voluntary data sharing within Precision Medicine

Genetics/Genomics in Public Health. Role of Clinical and Biochemical Geneticists in Public Health

Submission to House of Lords Science and Technology Select Committee Oxford Nanopore Technologies Ltd April 2008

Scientists don t yet fully

Personalized Human Genome Sequencing

Up Close and Personal

Introduction to Genomic Medicine Using Galaxy Platform (Workshop)

US Food and Drug Administration. Sandra L. Kweder, MD Deputy Director, Europe Office

Comments on Use of Databases for Establishing the Clinical Relevance of Human Genetic Variants

IDENTIFIABILITY OF THE HUMAN MICROBIOME: INVESTIGATOR PERSPECTIVES

Information Technology for Genetic and Genomic Based Personalized Medicine. Submitted. April 23, 2008

THE CAMPAIGN FOR UC SANTA CRUZ THE GENOMICS INSTITUTE

Frumkin, 2e Part 1: Methods and Paradigms. Chapter 6: Genetics and Environmental Health

US Policy Developments and Points to Consider for Genomics Research Informed Consent

Improving Population Health One Person at a Time

Biomedical Informatics in BIG DATA Era

Introduction to Bioinformatics

Complex Adaptive Systems Forum: Transformative CAS Initiatives in Biomedicine

- OMICS IN PERSONALISED MEDICINE

2017 Amplyus, all rights reserved

Machine learning applications in genomics: practical issues & challenges. Yuzhen Ye School of Informatics and Computing, Indiana University

GENETIC TESTING A Resource from the American College of Preventive Medicine

Challenges and Issues for Pharmacogenomics Data Review in the FDA s VGDS Program

Challenges of Personalized Health for Clinical Medicine. Peter J Meier-Abt Swiss Academy of Medical Sciences (SAMS) Berne, Switzerland

Pharmacogenetics: A SNPshot of the Future. Ani Khondkaryan Genomics, Bioinformatics, and Medicine Spring 2001

PMHDC Principal Investigators:

Genomic Research: Issues to Consider. IRB Brown Bag August 28, 2014 Sharon Aufox, MS, LGC

Reporting Results and Incidental Findings to Research Participants

PERSONALISED MEDICINE FOR THE BENEFIT OF PATIENTS

University of Athens - Medical School. pmedgr. The Greek Research Infrastructure for Personalized Medicine

Genome Sequencing: Applications and Newborn Screening. June 2, 2014

BOARD PAPER - NHS ENGLAND. Purpose of Paper: To inform the Board of the development of an NHS England Personalised Medicine Strategy.

ACCELERATING GENOMIC ANALYSIS ON THE CLOUD. Enabling the PanCancer Analysis of Whole Genomes (PCAWG) consortia to analyze thousands of genomes

LARGE DATA AND BIOMEDICAL COMPUTATIONAL PIPELINES FOR COMPLEX DISEASES

Personalized. Health in Canada

GENOMICS HEALTH FUTURES MISSION

Eric Green NHGRI Director

Just the Facts: A Basic Introduction to the Science Underlying NCBI Resources

An innovative approach to genetic testing for improved patient care

IMI: Accelerated Drug Portal. Julia Brosnan on behalf of Innovative Medicines Initiative

PHYSICIAN RESOURCES MAPPED TO GENOMICS COMPETENCIES AND GAPS IDENTIFIED WITH CURRENT EDUCATIONAL RESOURCES AVAILABLE 06/04/14

All of Us Research Program

NIH Update James M. Anderson, M.D., Ph.D. NIH Deputy Director for Program Coordination, Planning, and Strategic Initiatives National Institutes of

GENOMICS for DUMMIES

Definition of Human Subject (94% oppose, 3% support, 3% support with qualifiers)

Nordic Common Strengths and Future Potential in the Field of Personalised Medicine

Ethics of Precision Medicine in Low to Middle Income Countries

The experience of Andalusia in ehealth and big data --- Big data in health - IMI s HARMONY project, European Parliament, Brussels, 19 June 2018

Your genes. Your roadmap. Health TechNet & Pharmacogenomics (PGx) February 16, Franziska Moeckel AVP, Personalized Health

PAREXEL GENOMIC MEDICINE SERVICES. Applying genomics to enhance your drug development journey

THE ERA OF INDIVIDUAL GENOMES. Sandra Viz Lasheras Advanced Genetics ( )

Lesson Overview. Studying the Human Genome. Lesson Overview Studying the Human Genome

Vision, aims and strategies. Department of Immunology, Genetics and Pathology Uppsala University

Satellite Education Workshop (SW4): Epigenomics: Design, Implementation and Analysis for RNA-seq and Methyl-seq Experiments

HRPP Policy No. 714 Effective Date 09/01/10 Revisions Date. Genome Wide Association Studies

BIOSPECIMENS AND DATA SHARING CONSIDERATIONS FOR NATIVE PEOPLES

Molecular Diagnostics

Pharmacogenetics of Drug-Induced Side Effects

The NHS approach to personalised medicine in respiratory disease. Professor Sue Chief Scientific Officer for England

Evaluation and Regulation of Biomarkers A Public Health Perspective

Visit our Career Flowchart to get more information on some of these career paths.

2018/2019 final draft National Genomic Test Directory FAQ

A New Era of Clinical Diagnostics: How the Business Model is Changing.

NETWORKING AND CUREACCELERATOR LIVE!

The H3Africa and H3ABioNet Infrastructure

Implications for the Future Issues in Ethics. David Castle Department of Philosophy University of Guelph

Studying the Human Genome. Lesson Overview. Lesson Overview Studying the Human Genome

Transforming care for the future

Learning Objectives. Introduction

Genomics and personalised medicine

TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS

Presidential Commission for the Study of Bioethical Issues 2 nd meeting September

The 100,000 Genomes Project

Transform Clinical Research Into Value-Based Personalized Care

Computational Biology

Overview of Health Informatics. ITI BMI-Dept

Danika Bannasch DVM PhD. School of Veterinary Medicine University of California Davis

Synthetic Viruses Targeting Cancer

INTERDISCIPLINARY COLLABORATIONS MEDICAL RECORDS AND GENOMICS (EMERGE) NETWORK AND EHRS: THE ELECTRONIC. October 30, 2015

Fundamentals of Clinical Genomics

impact on a trial design and labeling

Investimento & Inovação na Saúde

Indigenizing Genomics

The Human Genome Project

Measuring Chemicals in People What Would You Say? A Boston Consensus Conference on Biomonitoring. December 11, 2006

Frequently Asked Questions

Our website:

Proposed Recommendations of the European Society of Human Genetics

Integrating Genomics in Family Medicine

Genomes contain all of the information needed for an organism to grow and survive.

Community Health Initiative

Are Next-Generation HPC Systems Ready for Population-level Genomics Data Analytics?

Chairman Cole, Ranking Member DeLauro and distinguished members of the

Short Course Instructors

European Genome phenome Archive at the European Bioinformatics Institute. Helen Parkinson Head of Molecular Archives

October 6, Below we provide input from our community of health informatics experts regarding select portions of the Draft Guidance.

4 th ESPT SUMMER SCHOOL

Your story is unique. Diet & Exercise. Environment. Your health. Lifestyle. Genetics A PICTURE OF YOUR HEALTH

All research lines at the LMU have a strong methodological focus

Transcription:

Precision Medicine: Its Promises and Pitfalls Melissa S. Creary, PhD, MPH Health Management and Policy U-M School of Public Health

Today s Outline 1. How did we get here? 2. Personalized vs. Precision 3. National Initiative 4. U-M Precision Health Initiative 5. Ethical Concerns and Other Problems 6. Resources 7. Question and Answer

How did we get here? Human Genome Project (1990-2003) o identify all the approximately 20,000-25,000 genes in human DNA; providing the genetic blueprint for a human being o determine the sequences of the three billion chemical base pairs that make up human DNA; o store this information in databases; o improve tools for data analysis; o transfer related technologies to the private sector; and o address the ethical, legal and social issues that may arise from the project.

How did we get here? Human Genome Project (1990-2003) o U.S. National Research Council Mapping and Sequencing the Human Genome (1988) o $3 Billion o Supported by U.S. Department of Energy, the U.S. National Institutes of Health (NIH), international and domestic collaborators and spurred by private competition o 15 years working draft produced in 2000

What the HGP gave us o Deeper understanding of medicine o Genomic architecture of genetic diseases (rare easier than common) o Better, more efficient, cheaper technologies o Ways to better think about data management and security o The next next frontiers: proteomics, pharmacogenomics, the microbiome, epigenome

What the HGP gave us o Shortcut that linked particular gene variants with specific diseases GWAS (genome-wide association studies) o Genomic Medicine Medical discipline that involves using genomic information about an individual as part of their clinical care

Personalized vs. Precision Personalized Medicine implies the prospect of devising a different treatment for each individual patient On one hand, that s how medicine is practiced every day, and on the other, it s a complete fallacy. - David Altshuler, geneticist, Broad Institute in Cambridge, Massachusetts

Personalized vs. Precision focuses on classifying individuals into subpopulations that differ in their susceptibility to a particular disease or in their response to a specific treatment an approach to integrating clinical and molecular information to understand the biological basis of disease enable more patient-centered clinical practice more research-oriented vs. more clinical practiceoriented.

Precision Medicine o GWAS studies are too limited o More data is necessary from many more people o Superimpose the entire genome and that data with: family history microbiome epigenome

National Initiatives: PMI o Announced at the 2015 State of the Union address o Lead by the White House with an all of government effort o Guiding Principles Creating a dynamic and inclusive governance structure Building trust and accountability through transparency Respecting participant preferences Empowering participants through access to information.

National Initiatives: All of Us o Name Change in October 2016 o Resides primarily within the NIH ($130 M) o Goal: 1 Million participants for the largest longitudinal study in the history of the United States All of Us represents the hope for all of us to come together to change the future of health care. The more people across America that participate, the more data they contribute to this research platform, and the more researchers who tap into the data, the greater our chances of unlocking medical breakthroughs.

Core Values Participation is open to all. Participants reflect the rich diversity of the U.S. Participants are partners. Participants have access to their information. Data will be accessed broadly for research purposes. Security and privacy will be of highest importance. The program will be a catalyst for positive change in research. Volunteers will contribute their health data and biospecimens to a centralized national database National launch Spring 2018 Democratizing Data Citizen Science

Why Now?

U-M Precision Health Initiative Language Matters: Precision Health vs. Precision Medicine Precision health at the University of Michigan expands far beyond medical treatment to include prevention, implementation, and community health. This initiative actively bridges these areas by promoting multidisciplinary collaboration among faculty across the university.

U-M Precision Health Initiative

U-M Precision Health Initiative

U-M Precision Health Initiative

U-M Precision Health Initiative

Ethical Concerns and Other Problems 1. Benefits will be unevenly distributed o Socioeconomic status o Geography o Race o Gender

Ethical Concerns and Other Problems 2. Participant Engagement o Not subjects Partners o Building trust o Continuous measurement :: continuous consent o Participant fatigue o Diversity

Ethical Concerns and Other Problems 3. Data Collection, Security and Privacy o Large amounts of data to be managed o Provision of individual level data o Social media integration o Centralized records

Ethical Concerns and Other Problems 4. Emphasis on Biological Difference/Citizenship o Lessons learned from HGP o Genetic profiling o New modes of discrimination o Immigration

Ethical Concerns and Other Problems 5. Bounded Justice (Creary, 2016) An attempt to distribute health rights without disturbing the underlying mechanisms that generated initial inequalities

Resources 1. All of Us: https://allofus.nih.gov/ 2. U-M Precision Health: https://precisionhealth.umich.edu/ 3. Findings-SPH s Contribution to PH https://sph.umich.edu/findings/fall2017/ Reading List Available